Skip to main content
Top
Published in: Diabetologia 8/2016

Open Access 01-08-2016 | Article

Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity

Authors: Ahmad Al-Mrabeh, Kieren G. Hollingsworth, Sarah Steven, Roy Taylor

Published in: Diabetologia | Issue 8/2016

Login to get access

Abstract

Aims/hypothesis

This study was designed to establish whether the low volume and irregular border of the pancreas in type 2 diabetes would be normalised after reversal of diabetes.

Methods

A total of 29 individuals with type 2 diabetes undertook a very low energy (very low calorie) diet for 8 weeks followed by weight maintenance for 6 months. Methods were established to quantify the pancreas volume and degree of irregularity of the pancreas border. Three-dimensional volume-rendering and fractal dimension (FD) analysis of the MRI-acquired images were employed, as was three-point Dixon imaging to quantify the fat content.

Results

There was no change in pancreas volume 6 months after reversal of diabetes compared with baseline (52.0 ± 4.9 cm3 and 51.4 ± 4.5 cm3, respectively; p = 0.69), nor was any volumetric change observed in the non-responders. There was an inverse relationship between the volume and fat content of the pancreas in the total study population (r =−0.50, p = 0.006). Reversal of diabetes was associated with an increase in irregularity of the pancreas borders between baseline and 8 weeks (FD 1.143 ± 0.013 and 1.169 ± 0.006, respectively; p = 0.05), followed by a decrease at 6 months (1.130 ± 0.012, p = 0.006). On the other hand, no changes in FD were seen in the non-reversed group.

Conclusions/interpretation

Restoration of normal insulin secretion did not increase the subnormal pancreas volume over 6 months in the study population. A significant change in irregularity of the pancreas borders occurred after acute weight loss only after reversal of diabetes. Pancreas morphology in type 2 diabetes may be prognostically important, and its relationship to change in beta cell function requires further study.
Appendix
Available only for authorised users
Literature
1.
go back to reference Hruban RH (2004) History of the pancreas: mysteries of a hidden organ. Bull Hist Med 78:506–507CrossRef Hruban RH (2004) History of the pancreas: mysteries of a hidden organ. Bull Hist Med 78:506–507CrossRef
2.
go back to reference Williams AJ, Chau W, Callaway MP, Dayan CM (2007) Magnetic resonance imaging: a reliable method for measuring pancreatic volume in type 1 diabetes. Diabet Med 24:35–40CrossRefPubMed Williams AJ, Chau W, Callaway MP, Dayan CM (2007) Magnetic resonance imaging: a reliable method for measuring pancreatic volume in type 1 diabetes. Diabet Med 24:35–40CrossRefPubMed
3.
go back to reference Williams AJ, Thrower SL, Sequeiros IM et al (2012) Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab 97:E2109–E2113CrossRefPubMed Williams AJ, Thrower SL, Sequeiros IM et al (2012) Pancreatic volume is reduced in adult patients with recently diagnosed type 1 diabetes. J Clin Endocrinol Metab 97:E2109–E2113CrossRefPubMed
4.
5.
go back to reference Burute N, Nisenbaum R, Jenkins DJ et al (2014) Pancreas volume measurement in patients with type 2 diabetes using magnetic resonance imaging-based planimetry. Pancreatology 14:268–274CrossRefPubMed Burute N, Nisenbaum R, Jenkins DJ et al (2014) Pancreas volume measurement in patients with type 2 diabetes using magnetic resonance imaging-based planimetry. Pancreatology 14:268–274CrossRefPubMed
6.
go back to reference Macauley M, Percival K, Thelwall PE, Hollingsworth KG, Taylor R (2015) Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One 10:e0126825CrossRefPubMedPubMedCentral Macauley M, Percival K, Thelwall PE, Hollingsworth KG, Taylor R (2015) Altered volume, morphology and composition of the pancreas in type 2 diabetes. PLoS One 10:e0126825CrossRefPubMedPubMedCentral
7.
go back to reference Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506–2514CrossRefPubMedPubMedCentral Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R (2011) Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia 54:2506–2514CrossRefPubMedPubMedCentral
8.
go back to reference Steven S, Taylor R (2015) Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration type 2 diabetes. Diabet Med 32:1149–1155CrossRefPubMed Steven S, Taylor R (2015) Restoring normoglycaemia by use of a very low calorie diet in long- and short-duration type 2 diabetes. Diabet Med 32:1149–1155CrossRefPubMed
9.
go back to reference Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiologic changes in responders and non-responders. Diabetes Care. doi:10.2337/dc15-1942 Steven S, Hollingsworth KG, Al-Mrabeh A et al (2016) Very low calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiologic changes in responders and non-responders. Diabetes Care. doi:10.​2337/​dc15-1942
10.
go back to reference Lopes R, Betrouni N (2009) Fractal and multifractal analysis: a review. Med Image Anal 13:634–649CrossRefPubMed Lopes R, Betrouni N (2009) Fractal and multifractal analysis: a review. Med Image Anal 13:634–649CrossRefPubMed
11.
go back to reference Lennon FE, Cianci GC, Cipriani NA et al (2015) Lung cancer—a fractal viewpoint. Nat Rev Clin Oncol 12:664–675CrossRefPubMed Lennon FE, Cianci GC, Cipriani NA et al (2015) Lung cancer—a fractal viewpoint. Nat Rev Clin Oncol 12:664–675CrossRefPubMed
12.
go back to reference Weibel E (2005) Mandelbrot’s fractals and the geometry of life: a tribute to Benoît Mandelbrot on his 80th birthday. In: Losa G, Merlini D, Nonnenmacher T, Weibel E (eds) Fractals in biology and medicine. Birkhäuser, Basel, pp 3–16CrossRef Weibel E (2005) Mandelbrot’s fractals and the geometry of life: a tribute to Benoît Mandelbrot on his 80th birthday. In: Losa G, Merlini D, Nonnenmacher T, Weibel E (eds) Fractals in biology and medicine. Birkhäuser, Basel, pp 3–16CrossRef
13.
go back to reference Dioguardi N, Franceschini B, Aletti G, Russo C, Grizzi F (2003) Fractal dimension rectified meter for quantification of liver fibrosis and other irregular microscopic objects. Anal Quant Cytol Histol 25:312–320PubMed Dioguardi N, Franceschini B, Aletti G, Russo C, Grizzi F (2003) Fractal dimension rectified meter for quantification of liver fibrosis and other irregular microscopic objects. Anal Quant Cytol Histol 25:312–320PubMed
14.
go back to reference Dioguardi N, Grizzi F, Franceschini B, Bossi P, Russo C (2006) Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst’s exponent. World J Gastroenterol 12:2187–2194CrossRefPubMedPubMedCentral Dioguardi N, Grizzi F, Franceschini B, Bossi P, Russo C (2006) Liver fibrosis and tissue architectural change measurement using fractal-rectified metrics and Hurst’s exponent. World J Gastroenterol 12:2187–2194CrossRefPubMedPubMedCentral
15.
go back to reference Soda G, Nardoni S, Bosco D, Grizzi F, Dioguardi N, Melis M (2003) Fractal analysis of liver fibrosis. Pathologica 95:98–102PubMed Soda G, Nardoni S, Bosco D, Grizzi F, Dioguardi N, Melis M (2003) Fractal analysis of liver fibrosis. Pathologica 95:98–102PubMed
16.
go back to reference Moal F, Chappard D, Wang J et al (2002) Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology 36:840–849CrossRefPubMed Moal F, Chappard D, Wang J et al (2002) Fractal dimension can distinguish models and pharmacologic changes in liver fibrosis in rats. Hepatology 36:840–849CrossRefPubMed
17.
go back to reference Pantic I, Nesic D, Stevanovic D, Starcevic V, Pantic S, Trajkovic V (2013) Effects of ghrelin on the structural complexity of exocrine pancreas tissue architecture. Microsc Microanal 19:553–558CrossRefPubMed Pantic I, Nesic D, Stevanovic D, Starcevic V, Pantic S, Trajkovic V (2013) Effects of ghrelin on the structural complexity of exocrine pancreas tissue architecture. Microsc Microanal 19:553–558CrossRefPubMed
18.
go back to reference Pantic I, Paunovic J, Basta-Jovanovic G, Perovic M, Pantic S, Milosevic NT (2013) Age-related reduction of structural complexity in spleen hematopoietic tissue architecture in mice. Exp Gerontol 48:926–932CrossRefPubMed Pantic I, Paunovic J, Basta-Jovanovic G, Perovic M, Pantic S, Milosevic NT (2013) Age-related reduction of structural complexity in spleen hematopoietic tissue architecture in mice. Exp Gerontol 48:926–932CrossRefPubMed
19.
go back to reference Davnall F, Yip CS, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589CrossRefPubMedPubMedCentral Davnall F, Yip CS, Ljungqvist G et al (2012) Assessment of tumor heterogeneity: an emerging imaging tool for clinical practice? Insights Imaging 3:573–589CrossRefPubMedPubMedCentral
20.
21.
go back to reference Rajagopalan V, Liu Z, Allexandre D et al (2013) Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study. PLoS One 8:e73614CrossRefPubMedPubMedCentral Rajagopalan V, Liu Z, Allexandre D et al (2013) Brain white matter shape changes in amyotrophic lateral sclerosis (ALS): a fractal dimension study. PLoS One 8:e73614CrossRefPubMedPubMedCentral
22.
go back to reference Al-Kadi OS, Watson D (2008) Texture analysis of aggressive and nonaggressive lung tumor CE CT images. IEEE Trans Biomed Eng 55:1822–1830CrossRefPubMed Al-Kadi OS, Watson D (2008) Texture analysis of aggressive and nonaggressive lung tumor CE CT images. IEEE Trans Biomed Eng 55:1822–1830CrossRefPubMed
23.
go back to reference Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675CrossRefPubMed Schneider CA, Rasband WS, Eliceiri KW (2012) NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9:671–675CrossRefPubMed
24.
go back to reference Limaye A (2012) Drishti: a volume exploration and presentation tool. Proc. SPIE 8506, Developments in X-Ray Tomography VIII, 85060X (October 17, 2012); doi:10.1117/12.935640 Limaye A (2012) Drishti: a volume exploration and presentation tool. Proc. SPIE 8506, Developments in X-Ray Tomography VIII, 85060X (October 17, 2012); doi:10.​1117/​12.​935640
26.
go back to reference Hollingsworth KG, Al-Mrabeh A, Steven S, Taylor R (2015) Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia 58:2676–2678CrossRefPubMed Hollingsworth KG, Al-Mrabeh A, Steven S, Taylor R (2015) Pancreatic triacylglycerol distribution in type 2 diabetes. Diabetologia 58:2676–2678CrossRefPubMed
27.
go back to reference Alzaid A, Aideyan O, Nawaz S (1993) The size of the pancreas in diabetes mellitus. Diabet Med 10:759–763CrossRefPubMed Alzaid A, Aideyan O, Nawaz S (1993) The size of the pancreas in diabetes mellitus. Diabet Med 10:759–763CrossRefPubMed
28.
go back to reference Saisho Y, Butler AE, Meier JJ et al (2007) Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 20:933–942CrossRefPubMedPubMedCentral Saisho Y, Butler AE, Meier JJ et al (2007) Pancreas volumes in humans from birth to age one hundred taking into account sex, obesity, and presence of type-2 diabetes. Clin Anat 20:933–942CrossRefPubMedPubMedCentral
29.
go back to reference Goda K, Sasaki E, Nagata K, Fukai M, Ohsawa N, Hahafusa T (2001) Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol 38:145–149CrossRefPubMed Goda K, Sasaki E, Nagata K, Fukai M, Ohsawa N, Hahafusa T (2001) Pancreatic volume in type 1 and type 2 diabetes mellitus. Acta Diabetol 38:145–149CrossRefPubMed
30.
go back to reference Lim S, Bae JH, Chun EJ et al (2014) Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol 51:739–748CrossRefPubMed Lim S, Bae JH, Chun EJ et al (2014) Differences in pancreatic volume, fat content, and fat density measured by multidetector-row computed tomography according to the duration of diabetes. Acta Diabetol 51:739–748CrossRefPubMed
31.
go back to reference Poggi C, Le Marchand-Brustel Y, Zapf J, Froesch ER, Freychet P (1979) Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 105:723–730CrossRefPubMed Poggi C, Le Marchand-Brustel Y, Zapf J, Froesch ER, Freychet P (1979) Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 105:723–730CrossRefPubMed
32.
go back to reference Carey PE, Gerrard J, Cline GW et al (2005) Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production. Am J Physiol Endocrinol Metab 289:E941–E947CrossRefPubMed Carey PE, Gerrard J, Cline GW et al (2005) Acute inhibition of lipolysis does not affect postprandial suppression of endogenous glucose production. Am J Physiol Endocrinol Metab 289:E941–E947CrossRefPubMed
33.
go back to reference Foulis AK, Frier BM (1984) Pancreatic endocrine-exocrine function in diabetes: an old alliance disturbed. Diabet Med 1:263–266CrossRefPubMed Foulis AK, Frier BM (1984) Pancreatic endocrine-exocrine function in diabetes: an old alliance disturbed. Diabet Med 1:263–266CrossRefPubMed
34.
go back to reference Saisho Y, Manesso E, Butler AE et al (2011) Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetes. Diabetes 60:848–856CrossRefPubMedPubMedCentral Saisho Y, Manesso E, Butler AE et al (2011) Ongoing beta-cell turnover in adult nonhuman primates is not adaptively increased in streptozotocin-induced diabetes. Diabetes 60:848–856CrossRefPubMedPubMedCentral
35.
go back to reference Hahn PF (1999) Biliary system, pancreas, spleen and alimentary tract. In: Stark DD, Bradley WG (eds) Magnetic resonance imaging. Mosby, St Louis, pp 471–501 Hahn PF (1999) Biliary system, pancreas, spleen and alimentary tract. In: Stark DD, Bradley WG (eds) Magnetic resonance imaging. Mosby, St Louis, pp 471–501
36.
go back to reference Murtaugh LC, Keefe MD (2015) Regeneration and repair of the exocrine pancreas. Annu Rev Physiol 77:229–249CrossRefPubMed Murtaugh LC, Keefe MD (2015) Regeneration and repair of the exocrine pancreas. Annu Rev Physiol 77:229–249CrossRefPubMed
Metadata
Title
Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin secretory capacity
Authors
Ahmad Al-Mrabeh
Kieren G. Hollingsworth
Sarah Steven
Roy Taylor
Publication date
01-08-2016
Publisher
Springer Berlin Heidelberg
Published in
Diabetologia / Issue 8/2016
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-016-3984-6

Other articles of this Issue 8/2016

Diabetologia 8/2016 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.